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Abstract
Background To analyze the organ donation action in population-based neurointensive care of acute aneurysmal subarachnoid
hemorrhage (aSAH) and to seek factors that would improve the identification of potential organ donors (PODs) and increase the
donor conversion rate (DCR) after aSAH.
Methods The Kuopio Intracranial Aneurysm Database, prospective since 1995, includes all aSAH patients admitted to the
Kuopio University Hospital (KUH) from its defined Eastern Finnish catchment population. We analyzed 769 consecutive acute
aSAH patients from 2005 to 2015, including their data from the Finnish Transplantation Unit and the national clinical registries.
We analyzed PODs vs. actual donors among the 145 (19%) aSAH patients who died within 14 days of admission. Finland had
implemented the national presumed consent (opt-out) within the study period in the end of 2010.
Results We retrospectively identified 83 (57%) PODs while only 49 (34%) had become actual donors (total DCR 59%); the
causes for non-donorship were 15/34 (44%) refusals of consent, 18/34 (53%) medical contraindications for donation, and 1/34
(3%) failure of recognition. In 2005–2010, there were 11 refusals by near relatives with DCR 52% (29/56) and only three in
2011–2015 with DCR 74% (20/27). Severe condition on admission (Hunt and Hess grade IVor V) independently associated with
the eventual POD status.
Conclusions Nearly 20% of all aSAH patients acutely admitted to neurointensive care from a defined catchment population died
within 14 days, almost half from cardiopulmonary causes at a median age of 69 years. Of all aSAH patients, 11%were considered
as potential organ donors (PODs). Donor conversion rate (DCR) was increased from 52 to 74% after the national presumed
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consent (opt-out). Implicitly, DCR among aSAH patients could be increased by admitting them to the intensive care regardless of
dismal prognosis for the survival, along a dedicated organ donation program for the catchment population.
Keywords Brain death . Intensive care . Intracranial aneurysm . Organ donation . Potential organ donor . Subarachnoid
hemorrhage
Introduction
The shortage of donated organs and the high mortality in the
waiting lists for transplantation are a worldwide challenge,
also in all European countries [7, 19]. Leading causes of brain
death during intensive care include aneurysmal subarachnoid
hemorrhage (aSAH) [6, 18], spontaneous intracerebral hem-
orrhage (ICH), and traumatic brain injury (TBI) [7, 12, 17,
20]. In a Canadian population-based cohort (1994–2011), on-
ly 1930 (2.2%) of the 87,129 patients who died from acute
brain catastrophe (TBI, SAH, ICH, others) became actual or-
gan donors; SAH led two times more often to organ donation
than TBI [17]. In a Southern Finnish cohort of 955 acute ICH
patients (2005–2010), 254 (27%) had diedwithin 14 days, and
only eight (3%) ended up as organ donors [20]. Improved
donor conversion rates (DCRs) would alleviate the chronic
shortage of legally transplantable organs [2]. In case of brain
death during intensive care, main reasons for refraining from
organ donation are reported to be (i) medical unsuitability and
(ii) refusal of consent by near relatives [7, 12, 17]. In addition,
acute care physicians may not admit patients with dismal
prognosis for the survival after acute brain catastrophes to
intensive care as potential organ donors (PODs).
In 2010, an international expert panel (neurology,
neurotraumatology, intensive care medicine, transplantation
medicine, intensive care ethics, and organ procurement man-
agement) suggested criteria for intensive care to identify a
patient with a reasonable probability to become brain dead
(imminent brain death) after acute brain catastrophe [3]. Two
validated coma scales (Glasgow Coma Scale and the FOUR
Score), brain stem reflexes, and respiration were used to de-
fine imminent brain death. The algorithm defined an actual
pool of potential organ donors (PODs), with the exclusion of
advanced age and medical contraindications.
In 2017 in Finland (population 5.5 million), 374 recipients
received organs from a total of 116 donors, 29 of them live near-
relative donors of kidneys (Finnish National Transplantation
Registry). In the national waiting list, including 460 kidney pa-
tients in dialysis, 2–10% had died or became withdrawn, de-
pending on the organ needed. To improve national DCR, the
presumed consent (opt-out) was implemented in 2010. Organ
donation after cardiac arrest has not been assigned in Finland.
To date, few studies have analyzed DCR in aSAH [7, 12,
15, 17]. The Kuopio Intracranial Aneurysm Patient and Family
Database includes all aSAH patients admitted to the Kuopio
University Hospital (KUH) from its defined Eastern Finnish
catchment population [8]. In our previous study, the mortality
of 1657 aSAH patients after acute hospitalization in1980–2007
was 11% at 3 days, 22% at 30 days, and 27% at 12 months
[10]. In the present study, we analyzed 769 consecutive acute
aSAH patients admitted to KUH Neurointensive Care from
2005 to 2015, including their data from the Finnish
Transplantation Unit and the national clinical registries. We
identified and analyzed PODs to seek factors that would (i)
improve the identification of PODs and (ii) increase DCR after
aSAH.
Methods and materials
Brain death and organ donor action in Finland
Finland implemented brain death in 1971 [11]. The national
guidelines on organ donation and transplantation by the
Ministry of Social Affairs and Health define two types of
death: brain death and cardiac death. Brain death due to an
acute brain catastrophe is diagnosed, after exclusion of con-
founding factors, by a board-certified neurosurgeon, neurolo-
gist, or pediatric neurologist, together with a board-certified
anesthesiologist or intensivist. The diagnosis is based on the
clinical examination, verification of the absence of brain stem
reflexes and the absence of spontaneous breathing with arte-
rial partial pressure of blood carbon dioxide ≥ 8 kPa [16]. The
absence of brain arterial circulation can be verified by CT
angiography or 4-vessel catheter angiography, but is not man-
datory. In Finland, all organ removals and transplantations are
performed and archived by the Transplantation Center of the
Helsinki University Hospital (HUS). All donors and recipients
are also registered in Scandiatransplant, the official organ ex-
change organization of Nordic Countries.
Kuopio University Hospital (KUH) and aSAH
management protocol in Eastern Finland
KUH, one of the five university hospitals in Finland, is an
academic, non-profit, publicly funded tertiary center, serving
a defined catchment population in Eastern Finland (Fig. 1).
The KUH area contains four central hospitals with catchment
areas of their own (Fig. 1), providing full-time neurology,
intensive care, and CT services.
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KUH Neurosurgery and KUH Neurointensive Care have
exclusively provided full-time (7 days, 24 h) acute and elec-
tive neurosurgical services for the KUH catchment population
[8–10]. All cases of SAH diagnosed by CT or spinal tap are
acutely transferred to KUH for neurointensive care, neurora-
diology (4-vessel catheter angiography and/or CT angiogra-
phy), and neurosurgical treatment.
Neurointensive care is provided regardless of the condition
on admission, including Hunt and Hess comatose grade V pa-
tients. A dedicated team of neurointensivists, neurosurgeons,
and neuroradiologists coordinates the aSAH treatment. KUH
Neurovascular group provides microsurgical or endovascular
occlusion of the ruptured aneurysm; cases with significant
ICH are immediately treated microsurgically. The protocol fol-
lows international recommendations in detail [5, 14, 21],
aiming to prevent further brain damage due to re-bleeding,
increased intracranial pressure (ICP), hydrocephalus, electro-
lyte disturbances, seizures, cardiac and pulmonary dysfunction,
fever, hyperglycemia, and development of delayed brain ische-
mia. The protocol includes, when appropriate, e.g., external
ventricular drainage (EVD), parenchymal ICP monitoring,
endovascular procedures, and intra-arterial nimodipine infusion
in case of delayed brain ischemia, as well as decompressive
craniectomy (DC).
Fig. 1 Map of the catchment area
of the Kuopio University Hospital
(KUH), containing 4 central
hospitals (Joensuu, Jyväskylä,
Mikkeli, Savonlinna) with acute
neurology and CT services. All
patients with acute aSAH are
referred to KUH Neurosurgery
and KUH Neurointensive Care
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Kuopio Intracranial Aneurysm Patient and Family
Database
This database, prospective since 1995, contains all of the pa-
tients, including family history, with angiographically verified
aSAH from the KUH catchment population. The phenotype
and outcome of intracranial aneurysm disease in Eastern
Finland have been analyzed in several studies [8–10]. The
clinical data, using the Finnish personal codes, have been
fused from the national registries, including prescribed medi-
cines, hospital diagnoses, and causes of death (Table 1).
Study population
The basic study population consisted of 769 consecutive,
acutely admitted, angiographically verified aSAH patients to
KUHNeurointensive Care from the Eastern Finnish catchment
population from 2005 to 2015 (flowchart in Fig. 2, Table 1). Of
the 769 aSAH patients, 145 (19%) had died within 14 days of
admission (Fig. 2, Table 1), a time period at neurointensive
care considered acceptable for organ donation.
Reconstruction of the clinical lifelines of the study
population
The clinical lifelines of the 769 aSAH patients have been
constructed using their clinical data from the Kuopio database
and the national clinical registries until death or the last fol-
low-up. For the 145 aSAH patients, dead within 14 days of
admission, data in the National Organ Transplantation Center
was reviewed for actual organ donations.
Literature review
PubMed search in January 2018 for English articles in humans
between 1995 and 2018 with the search words: (subarachnoid
hemorrhage) and ((brain death) and (donor* or donation* or
transplantation*) gave 43 hits. We reviewed these articles and
their reference lists, and identified four relevant cohorts [7, 12,
15, 17].
Definition of potential organ donors (PODs)
in the present study
In 2010, an international expert panel (neurology,
neurotraumatology, intensive care medicine, transplantation
medicine, intensive care ethics, and organ procurement man-
agement) suggested criteria for intensive care to identify a
patient with a reasonable probability to become brain dead
(imminent brain death) after acute brain catastrophe [3]. Two
validated coma scales (Glasgow Coma Scale and the FOUR
Score), brain stem reflexes, and respiration were used to de-
fine imminent brain death (Table 2). The algorithm defined an
actual pool of potential organ donors (PODs), with the exclu-
sion of advanced age and medical contraindications.
In the present study, we analyzed in retrospect PODs
among the 769 aSAH patients until death within 14 days
after acute admission to neurointensive care. The POD
criteria above were used, with two exceptions: absence
of only two brain stem reflexes, no strict exclusion criteria
for advanced age or medical conditions on admission
(Table 2).
Statistical methods
The categorical variables were expressed in proportions and
the continuous variables in medians, quartiles, and ranges.
Groups were compared using the Pearson χ2 test, the
Mann–Whitney U test, or the independent sample t test, when
appropriate. Independent risk factors for becoming a POD
after aSAH were examined using the logistic regression anal-
ysis enter method. P values < 0.05 were considered signifi-
cant. SPSS 22 statistical software was used for the analyses
(SPSS, Inc., Chicago, IL).
Ethical aspects
The Research Ethics Committee of the Kuopio University
Hospital approved the study. Data fusion from the national
registries was performed with approval from the Ministry of
Social Affairs and Health of Finland. Kuopio Neurosurgery
Intracranial Aneurysm Study Group has received consent
from all patients recorded in the database. A separate written
consent for the national register data fusion was not required
by the Ministry of Social Affairs and Health.
Results
Study population
Between 2005 and 2015, a total of 769 aSAH patients (Fig. 2,
Table 1) had been acutely admitted to KUH Neurointensive
Care from a defined catchment population (Fig. 1), and 145
(19%) of them had died within 14 days of admission (flow-
chart in Fig. 2). Table 2 presents the distribution of their clin-
ical variables.
Potential organ donors
Of the 145 aSAH patients who died within 14 days, 62 (43%)
had died of cardiopulmonary causes: their median age was
69 years (range 40–86) and 34 (55%) had drug-treated hyper-
tension (Table 2). We retrospectively identified 83 (57%) po-
tential organ donors (PODs) (Table 2), using the POD criteria
in Table 1 in BMaterials and Methods.^ Their median age was
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56 (range 30–85) and 29 (34%) had hypertension. Reflecting
their moribund condition on admission, 57 (69%) had not had
occlusive therapy of the ruptured aneurysm, as against 93
(12%) of all 769 aSAH patients (Table 2). Severe condition
on admission (Hunt and Hess grade IV or V) was indepen-
dently associated with the eventual POD status (Table 3).
Causes for non-donorship
Only 49 of the 83 PODs had become actual donors (Table 2), a
donor conversion rate (DCR) of 59% in retrospect.
The causes for non-donorship among the 34 PODs
were 15/34 (44%) refusals of consent; 18/34 (53%) pa-
tients with medical unsuitability for donation; and 1/34
(3%) violation of the protocol and failure to recognize
POD (Fig. 2).
Presumed consent and refusals of consent
Finland had implemented the national presumed consent (opt-
out) within the study period in the end of 2010. In 2005–2010,
there were 11 refusals by near relatives with DCR 52% (29/
56), but only three in 2011–2015 with DCR 74% (20/27).
Table 1 Characteristics of the 769 consecutive aneurysmal
subarachnoid hemorrhage (aSAH) patients acutely admitted to the
Neurointensive Care of Kuopio University Hospital from its Eastern
Finnish catchment population from 2005 to 2015. Characteristics of the
145 patients who died within 14 days after admission are presented
according to their organ donor status
All aSAH
patients n = 769
aSAH patients dead within 14 days after admission to neurointensive care
All
n = 145
Potential organ donors (PODs) in retrospect
n = 83/145 (57%)
Cardiac death




n = 49/83 (59%)
Non-donors
n = 34/83 (41%)
Median age (years) 55 (17–87) 60 (30–86) 56 (30–85) 49 (33–72) 63 (30–85) 69 (40–86)























































































Median aneurysm size 7 mm 8 mm 10 mm 10 mm 9.5 mm 7 mm
Multiple aneurysms 232 (30%) 34 (23%) 19 (23%) 9 (18%) 10 (29%) 15 (24%)
ICH 220 (29%) 68 (48%) 39 (47%) 23 (47%) 16 (47%) 30 (48%)
IVH 291 (38%) 100 (69%) 56 (68%) 32 (66%) 24 (71%) 44 (71%)























Decompressive craniectomy 46 (6%) 14 (10%) 3 (4%) 3 (6%) 0 11 (18%)
Median time to death from
admission (days)
N/A 3 (0–14) 1 (0–14) 1 (0–14) 1 (0–12) 8 (0–14)
ICH intracerebral hematoma, IVH intraventricular hematoma, ACA anterior cerebral artery, peripheral segments and anterior communicating artery, BA
basilar artery trunk and bifurcation, ICA internal carotid artery trunk and bifurcation, posterior communicating artery, MCA middle cerebral artery and
peripheral segments, PICA posterior inferior cerebellar artery
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There was one patient who had denied own organ donation
during life.
Decompressive craniectomy
Of the 769 aSAH patients, 46 (6%) had had decompressive
craniectomy (DC), an option through the study period
(Table 1). Small sample size did not allow the evaluation of
the impact of DC on relative mortality rates.
Discussion
Essential results of the present study
We analyzed 769 consecutive acute aSAH patients in a pro-
spectively collected database, admitted between 2005 and
2015 to the neurointensive care unit of a university hospital,
solely serving a defined catchment population, also using their
data from the national transplantation registry and other clinical
registries. In our population-based practice, we started in 2004
to admit virtually all aSAH patients to acute neurointensive
care, also as PODS, almost regardless of the age (oldest
87 years), previous medical conditions, or dismal prognosis
for the survival. In retrospect, we identified 83 (57%) potential
organ donors (PODs) among the 145 aSAH patients who died
within 14 days of admission. Severe condition on admission
(Hunt and Hess grades IVor V) independently associated with
the eventual POD status (Table 3). Of the 83 PODs, only 49 had
become actual donors, due to 15 refusals of consent and 18
medical conditions unsuitable for donation. Finland had imple-
mented national presumed consent (opt-out) within the study
period in the end of 2010. There were 11 refusals in 2005–2010
with the donor conversion rate (DCR) of 52% and only three in
2011–2015 with DCR of 74%.
Severe clinical condition on admission for acute aSAH in
defined catchment populations associates with significant
mortality in neurointensive care. In our previous study, the
mortality of 1657 aSAH patients (1980–2007) was 22% at
KUH catchment population of approx. 
842,000 in 2015 in Eastern Finland 
Died within 14 days after aSAH 
n = 145 
Potential organ donors (PODs) 
 according to present standards
n = 83 / 145 (57%)
Organ donation
performed
n = 49 / 83 (59%)
Cardiac death 
n = 62 / 145 (43%)
Consent 
declined
n = 15 / 83
(18%)
aSAH patients admitted alive to KUH in  
2005 – 2015  n = 769 
Medical 
unsuitability* 




n = 1 / 83
(1%)
Fig. 2 A total of 769 patients had been admitted acutely for aneurysmal
subarachnoid hemorrhage (aSAH) to the neurosurgical and
neurointensive care at the Kuopio University Hospital (KUH) between
2005 and 2015 from its defined Eastern Finnish catchment population. A
total of 145 aSAH patients had died within 14 days, and 49 of them had
become actual organ donors. In retrospect, we identified 83 potential
organ donors (PODs) (Tables 1 and 2) and analyzed causes for the non-
donorship among the remaining 34 PODs. * Defined medical
unsuitability for organ donation: cardiovascular, pulmonary, diabetic
and/or renal conditions; autoimmune disease; systemic infection;
cardiac failure during donor management
Table 2 Definition of
potential organ donors
(PODs) in a previous
multi-disciplinary
consensus, as compared
to the present study of
aSAH patients
de Groot YJ, et al. 2010 [3]: Imminent brain death: point of departure for potential heart-beating organ donor recognition
* Known origin of catastrophic brain damage
* Condition considered irreversible
* Ventilated patient
* GCS 3
* Absence of 3 out of 6 brain stem reflexes
* Exclusion criteria: age; medical contraindications
The present study
* Catastrophic brain damage after aSAH
* Condition considered irreversible
* Ventilated patient
* GCS 3
* Absence of 2 out of 6 brain stem reflexes
* No exclusion by age or medical conditions on admission
Brain stem reflexes: pupillary reactivity to light, corneal reflex, oculocephalic response, oculovestibular responses, gag
reflex, and cough reflex
aSAH aneurysmal subarachnoid hemorrhage, GCS Glasgow Coma Scale
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30 days [10]. The independent risk factors were Hunt and
Hess grade V (OR 43) or IV (OR 10), age over 65 years
(OR 3.9), aneurysm size over 25 mm (OR 3.7), and IVH
(OR 1.8). In the present study, 71% of the grade V patients
and 26% of the grade IV patients died within 14 days, a time
period at neurointensive care considered acceptable for organ
donation in our practice. On the other hand, some of the grade
V patients may recover with a favorable outcome [4, 13].
In a Dutch university hospital, 179 (38%) of the 473 SAH
patients (1999–2003) had died during neurointensive care. Of
the 132 PODs, 35 had been treated until determination of the
brain death. With nine refusals, 26/132 (DCR 20%) became
organ donors [12]. In a German university hospital, 71 (18%)
of the 395 aSAH patients (2011–2016) admitted to the inten-
sive care unit had died [15]. Of the 36 PODs, 23 (DCR 64%)
became actual organ donors. In 13 patients, the consent had
been declined by a written will of the patient or by their closest
relatives.
The limitations and strengths of our study
The limitation of our study is that the POD status was eval-
uated retrospectively, albeit from prospectively collected
data in the database. The strengths derive from the
Finnish health care system. Finland is divided into mutual-
ly exclusive catchment areas among the 5 university hos-
pitals, allowing disease cohorts that are unselected and
minimally biased. The Kuopio Intracranial Aneurysm
Patient and Family Database reliably reflects aSAH in the
Eastern Finnish population and allows reconstruction of the
clinical lifelines of aSAH patients, also using data from the
national clinical registries. In Finland, all organ removals
and transplantations are performed and archived by the
Transplantation Center of the Helsinki University Hospital.
Finnish national policies to enhance donor action
Finland implemented national presumed consent (opt-out) in
the end of 2010, applying to brain-dead patients over 18 years
of age and with previous full capacity to make binding
amendments to their rights. The near relatives are informed
of the brain death and asked whether the brain-dead patient
had during life expressed refusal of own organ donation in
case of own brain death. The national goal is that 70% of
adults would express their opinion on organ donation by
2018. The Finnish National Archive for Health Information
(www.kanta.fi/en/) provides every citizen a possibility to enter
own opinion to an online platform, accessible at all times to
health care professionals. The near relatives do not have a
legal right of vetoing organ donation, but strict refusals are
respected in clinical practice. There were 11 refusals in 2005–
2010 with the DCR of 52% and only three in 2011–2015 with
the DCR of 74%. The numbers are too small to argue that the
presumed consent as such would have increased DCR, and
increased awareness of the donor action in neuroacutology
and neurointensive care, but our study suggests that it may
play a role.
Furthermore, a recent Finnish guideline recommends that
moribund brain catastrophe patients should be admitted to
intensive care as PODs, regardless of dismal prognosis for
the survival, along a dedicated organ donation program for
the catchment population. The impact of these national poli-
cies remains to be verified in large population-based cohorts.
Finally, the association of decompressive craniectomy and
DCR in intensive care of aSAH patients should be studied in
large collaborative cohorts [1]. The essential question is
whether decompressive craniectomy improves the survival
of aSAH patients rather than merely increases the time to
eventual death.
Conclusions
Nearly 20% of all aSAH patients acutely admitted to
neurointensive care from a defined catchment population died
within 14 days, almost half from cardiopulmonary causes at a
median age of 69 years. Of all aSAH patients, 11% were
considered as potential organ donors (PODs). Donor conver-
sion rate (DCR) was increased from 52 to 74% after the na-
tional presumed consent (opt-out). Implicitly, DCR among
aSAH patients could be increased by admitting them to the
intensive care regardless of dismal prognosis for the survival,
along a dedicated organ donation program for the catchment
population.
Authors’ contributions OP.K. analyzed the cohort, made statistical anal-
yses, and drafted the manuscript; J.H. made statistical analyses and
reviewed the manuscript; A.L. and M.L. performed data acquisition and
reviewed the manuscript; T.K., J.E.J, S.B., I.P., and A.U. reviewed the
manuscript. All authors reviewed and approved the final revised
manuscript.
Funding This study was supported by the Päivikki and Sakari Sohlberg
Foundation, Finnish Academy of Sciences, and Kuopio University
Hospital.
Table 3 Independent factors associating in multivariate analysis with
potential organ donor (POD) status (n = 83) among the 769 consecutive
aneurysmal subarachnoid hemorrhage (aSAH) patients acutely admitted
to the Neurointensive Care of Kuopio University Hospital from its
Eastern Finnish catchment population from 2005 to 2015
Variable OR P value CI (95%)
Hunt and Hess grade IV 6 0.04 1.1–34
Hunt and Hess grade V
(extension to pain)
20 0.01 3.3–117
No occlusion of aneurysm
due to moribund condition
25 < 0.01 8.1–79
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